Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 26 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 11236402

    Adeno-associated virus virions with variant capsid

    The Regents of the University of California · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  2. US 11236301

    Thin film cell encapsulation devices

    The Regents of the University of California · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  3. US 11235076

    Chelating platform for delivery of radionuclides

    The Regents of the University of California · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  4. US 11229681

    Dominant-negative FGF2 antagonists

    The Regents of the University of California · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  5. US 11230535

    CFTR regulators and methods of use thereof

    The Regents of the University of California · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  6. US 11224577

    Treating infection by a platelet-targeting microbe using nanoparticles

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  7. US 11225514

    Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  8. US 11225525

    Antibodies for botulinum neurotoxins

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  9. US 11224656

    Scintillator nanocrystal-containing compositions and methods for their use

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  10. US 11224655

    Targeting microbubbles

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  11. US 11224646

    Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  12. US 11224647

    Safe potent single platform vaccine against Tier 1 select agents and other pathogens

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  13. US 11224624

    Modulation of microbial synthesis of 4-etylphenol and 4-ethylphenyl sulfate in behavior and disease

    The Regents of the University of California · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted

  14. US 11220477

    Modulators of the eIF2alpha pathway

    The Regents of the University of California · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  15. US 11219697

    Osteoadsorptive fluorogenic substrate of cathepsin k for imaging osteoclast activity and migration

    The Regents of the University of California · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  16. US 11219692

    Porphyrin modified telodendrimers

    The Regents of the University of California · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  17. US 11213582

    Protection against recurrent genital herpes by therapeutic immunization with herpes simplex virus type 2 ribonucleotide reductase protein subunits

    The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  18. US 11213514

    Alpha-1-adrenergic receptor agonist therapy

    The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  19. US 11213513

    Compositions and methods for promoting hair growth with Mpc1 inhibitors

    The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  20. US 11215617

    Treatment of metastatic prostate cancer

    The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  21. US 11208493

    Internalizing human monoclonal antibodies targeting prostate and other cancer cells

    The Regents of the University of California · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  22. US 11208411

    Compositions and methods for treating parasitic diseases

    The Regents of the University of California · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  23. US 11208330

    Identification and optimization of carbon radicals on hydrated graphene oxide for ubiquitous antibacterial coatings

    The Regents of the University of California · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  24. US 11202801

    Notch receptors with hinge domain

    The Regents of the University of California, UCSF · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.